Literature DB >> 7028940

Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria.

C B Walker, J M Gordon, S J McQuilkin, T A Niebloom, S S Socransky.   

Abstract

The sensitivity to tetracycline of 345 bacterial isolates from periodontal lesions was determined. Most species of bacteria, including those thought to be involved in the initiation and progress of destructive periodontal disease, were inhibited in vitro by tetracycline concentrations of 4 to 8 micrograms/ml. This concentration is equivalent to crevicular fluid levels of tetracycline at dosages of 1 gm/day. These data indicate that tetracycline is inhibitory at levels achieved in crevicular fluid for bacteria currently implicated in destructive periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028940     DOI: 10.1902/jop.1981.52.10.613

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

1.  Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

Authors:  K Suomalainen; T Sorsa; L M Golub; N Ramamurthy; H M Lee; V J Uitto; H Saari; Y T Konttinen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Characterization of minocycline transport by human neutrophils.

Authors:  John D Walters
Journal:  J Periodontol       Date:  2006-12       Impact factor: 6.993

3.  An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

Authors:  James J Brayton; Qing Yang; Robin J Nakkula; John D Walters
Journal:  J Periodontol       Date:  2002-11       Impact factor: 6.993

4.  Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria.

Authors:  P J Baker; J Slots; R J Genco; R T Evans
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

5.  Antimicrobial susceptibilities of bacteria associated with periodontal disease.

Authors:  V L Sutter; M J Jones; A T Ghoneim
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

6.  Effects of Curcumin and Tetracycline Gel on Experimental Induced Periodontitis as an Anti-Inflammatory, Osteogenesis Promoter and Enhanced Bone Density through Altered Iron Levels: Histopathological Study.

Authors:  Chenar Anwar Mohammad; Khadeeja Mohammed Ali; Rafal AbdulRazaq Al-Rawi; Sarhang Sarwat Gul
Journal:  Antibiotics (Basel)       Date:  2022-04-13

7.  Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius.

Authors:  M S Lantz; T Ray; S Krishnasami; D E Pearson
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

8.  Kinetics of drug release from a biodegradable local drug delivery system and its effect on Porphyromonas gingivalis isolates: An in vitro study.

Authors:  Ranganathan Vijayalashmi; Sabitha Manhalore Ravindranath; Nadathur Doraiswamy Jayakumar; Sheeja H Vargheese; Kikkeri Laxminarayana Kumaraswamy
Journal:  J Indian Soc Periodontol       Date:  2013-07

9.  Experimental periodontal disease treatment by subgingival irrigation with tetracycline hydrochloride in rats.

Authors:  Leandro Araújo Fernandes; Thiago Marchi Martins; Juliano Milanezi de Almeida; Maria José Hitomi Nagata; Leticia Helena Theodoro; Valdir Gouveia Garcia; Alvaro Francisco Bosco
Journal:  J Appl Oral Sci       Date:  2010-12       Impact factor: 2.698

10.  Evaluation of the effect of allograft with doxycycline versus the allograft alone in the treatment of infrabony defects: A controlled clinical and radiographical study.

Authors:  Kulmeet Kaur; Poonam Sikri
Journal:  Dent Res J (Isfahan)       Date:  2013-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.